Veligrotug is a newly FDA-approved treatment that can target the proptosis associated with thyroid eye disease.
Michael Yen, MD
Advertisement
Oculosplastic surgeon at Baylor College of Medicine
Articles by Michael Yen, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About the FDA's Peptide Reversal
2
Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial
3
FDA Approves First Orexin Agonist for Narcolepsy Type 1
4
Student Mental Health, Success Tied to Future Health and Affordability
5